SGLT2 inhibitors may worsen heart failure outcomes from chemotherapy, highlighting the need for further long-term studies on ...

A University of Alberta research team has uncovered a new role for a genetic mutation previously known to be linked to ...

Nanomedicine uses ultra-small particles to deliver drugs directly to the tissues and cells that need them, improving ...

Aranscia® solutions help oncologists comply with new FDA warning label requiring  DPYD genetic testing in patients receiving select chemotherapies HOUSTON , Oct.

Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.

After retiring from baseball, Babe Ruth was diagnosed with cancer. He agreed to undergo experimental treatment that informs cancer care today.

UD researchers study how protein coatings influence nanoparticles' ability to avoid immune clearance and reach their ...

Some parents have reported positive changes in their kids after giving them the drug, but experts remain concerned about a ...

The HAIP is a small medical device placed beneath the skin that continuously pumps highly concentrated chemotherapy through ...

Marking a new milestone in the region’s oncology care, Burjeel Cancer Institute (BCI) has successfully performed the UAE’s ...

Black Diamond Therapeutics focuses on silevertinib, a next-gen EGFR inhibitor for NSCLC, after outlicensing its other lead asset to Servier.